MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Breast Cancer
-
-
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
-
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
-
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
-
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
-
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
-
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
-
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
-
Biomarkers in Tissue Samples From Older Women With Breast Cancer
-
Alliance Celebrates World Breast Cancer Research Day
This World Breast Cancer Research Day, the Alliance for Clinical Trials in Oncology is highlighting the importance of clinical research in advancing better treatments and improving early detection to ultimately help prevent and cure breast cancer. Although both men and women can develop breast cancer, the disease disproportionately affects women. On average, women in the…
Categories
Alliance Committee
Browse by Year